Carvedilol Tablet, Film Coated
Product Images NDC 71335-1407

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 71335-1407). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
A line graph comparing percent mortality over months between Carvedilol and placebo groups. The x-axis represents time in months (0 to 21), and the y-axis shows percent mortality (0 to 30%). Two lines plot mortality trends, with placebo consistently higher than Carvedilol, and a P-value of 0.0014 indicated on the chart.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
A forest plot chart depicting hazard ratios with confidence intervals for various patient subgroups, including men, women, age groups, race, diabetic status, ischemic condition, heart rate, systolic blood pressure, and spironolactone use. The horizontal axis represents hazard ratios from 0.0 to 2.0 with a vertical line at 1.0, indicating the reference point. Each subgroup has a point estimate and whiskers showing variability around the hazard ratio.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
A line graph comparing percent mortality over 24 months between two groups labeled 'Placebo' and 'Carvedilol.' The vertical axis shows percentage mortality from 0 to 30%, and the horizontal axis shows time in months from 0 to 24. The graph includes a statistical significance indicator of P = 0.03.*
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
A forest plot chart displaying hazard ratios with confidence intervals for various patient subgroups related to a clinical study. Subgroups include age, gender, timing post-myocardial infarction, prior beta-blocker use, Killip class, thrombolytic use, PTCA for MI, congestive heart failure, diuretic use, angina, hypertension, diabetes, heart rate, systolic blood pressure, and all patients. The chart visually compares risk across these categories.*
FDA Label Image

Label Image (Lbl713351407)

Label Image (Lbl713351407)
Label for Carvedilol 3.125 mg tablet, film coated, packaged by Bryant Ranch Prepack, Burbank, CA. The label notes the product is comparable to Coreg 3.125 mg tablet by Beximco Pharmaceuticals Limited. Storage instructions specify room temperature of 20°-25°C (68°-77°F). The package contains 30 tablets and displays the NDC 71335-1407-1 with an additional barcode and lot number.*
FDA Label Image

Structural Formula (Structure)

Structural Formula (Structure)
Chemical structure of carvedilol, illustrating its molecular arrangement including indole and methoxyphenyl groups connected by an ethanolamine side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.